Evotec receives important pre-clinical milestones as part of its multi-target alliance with Bayer HealthCare

  • Evotec AG announced today that its multi-target collaboration with Bayer HealthCare has reached two important pre-clinical milestones for the transition of two projects from the alliance portfolio into late-stage discovery and pre-clinical development for the treatment of endometriosis. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-receives-important-pre-clinical-milestones-as-part-of-its-multi-target-alliance-with-bayer-healthcare-11

    Du magst vielleicht auch